New York, USA – March 19, 2025 – Equipped with advanced technologies and services, such as DNA methylation analysis, multi-omics analysis and more, CD BioSciences is determined to propel aging-related studies toward new discoveries and a more comprehensive understanding of the aging process and age-related diseases through its integrated biological age clock technology platform.
Aging research is a rapidly evolving field that encompasses a wide range of scientific disciplines. While significant progress has been made, several challenges remain. For example, the biological mechanisms behind aging are not fully understood. Researchers are exploring various theories, such as telomere shortening, mitochondrial dysfunction, and epigenetic changes, but a comprehensive model that integrates these aspects is still lacking. Additionally, reliable biomarkers of aging that can predict biological age, longevity, and health span are waiting to be discovered. These challenges require more advanced technologies and interdisciplinary collaboration to address.
CD BioSciences is a research service provider dedicated to the world of aging research, serving emerging research on aging mechanisms, preclinical medicine discovery and development, as well as healthcare and skincare products. CD BioSciences’ sophisticated biological age clock technology platform utilizes DNA methylation, telomere measurement, transcriptome, proteome, and metabolome to guide researchers to better comprehend underlying aging processes and age-related diseases and make targeted interventions for age-related diseases.
At the core of CD BioSciences’ tech platform is its DNA methylation analysis service. CD BioSciences leverages next-generation sequencing (NGS) and advanced bioinformatics tools to provide highly accurate and comprehensive methylation profiles. It covers thousands of CpG sites associated with aging, enabling researchers to identify biomarkers of aging, assess the impact of lifestyle and environmental factors, and evaluate the efficacy of anti-aging interventions. With its high precision, scalability, and customizable solutions, this service is a game-changer for aging research.
To further enhance the understanding of aging, CD BioSciences offers a multi-omics analysis service that integrates data from genomics, transcriptomics, proteomics, and metabolomics. This service enables researchers to identify key molecular drivers of aging, discover novel biomarkers, and uncover potential therapeutic targets. Whether researchers are studying the role of mitochondrial dysfunction in aging or exploring the impact of cellular senescence, this service offers unparalleled insights to accelerate customers’ research.
The launch of CD BioSciences’ biological age clock technology platform marks a significant milestone in aging research. By combining advanced DNA methylation analysis and multi-omics analysis services, this platform empowers researchers to unravel the complexities of aging and develop innovative strategies to promote healthy longevity. Whether an academic researcher, a pharmaceutical company, or a biotech startup, CD BioSciences is a trusted partner in unlocking the potential of aging research.
About CD BioSciences
CD BioSciences is a research service provider specializing in aging research. It offers a comprehensive range of services, encompassing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products. With a team of experienced scientists and advanced facilities, CD BioSciences is committed to advancing the understanding of aging and developing innovative solutions to promote healthy aging.
Media ContactCompany Name: CD BioSciencesContact Person: Kikiwi DavisEmail: Send EmailPhone: 1-315-636-4280Country: United StatesWebsite: https://www.agingclocks.com
